

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of heart rate (GO:0010459) | 5.53775070 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.22115358 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.22115358 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.17361694 |
| 5 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.93587066 |
| 6 | regulation of hypersensitivity (GO:0002883) | 4.79152985 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.68796916 |
| 8 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.56288491 |
| 9 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.41862729 |
| 10 | positive regulation of mast cell degranulation (GO:0043306) | 4.41862729 |
| 11 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.35524947 |
| 12 | respiratory chain complex IV assembly (GO:0008535) | 4.20415737 |
| 13 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.99575710 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 3.96841274 |
| 15 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.96604094 |
| 16 | respiratory electron transport chain (GO:0022904) | 3.94214057 |
| 17 | electron transport chain (GO:0022900) | 3.94031285 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.89768431 |
| 19 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.80348078 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 3.78187278 |
| 21 | mast cell activation (GO:0045576) | 3.69289388 |
| 22 | cell wall macromolecule catabolic process (GO:0016998) | 3.68499081 |
| 23 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.61469574 |
| 24 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 3.58752962 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.58019055 |
| 26 | peptidyl-histidine modification (GO:0018202) | 3.55967818 |
| 27 | hydrogen ion transmembrane transport (GO:1902600) | 3.53083836 |
| 28 | negative regulation of mast cell activation (GO:0033004) | 3.51762468 |
| 29 | centriole replication (GO:0007099) | 3.42192664 |
| 30 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.36486333 |
| 31 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.35401276 |
| 32 | mast cell degranulation (GO:0043303) | 3.33442065 |
| 33 | mast cell activation involved in immune response (GO:0002279) | 3.33442065 |
| 34 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.32460846 |
| 35 | proton transport (GO:0015992) | 3.31456627 |
| 36 | sequestering of actin monomers (GO:0042989) | 3.26573811 |
| 37 | hydrogen transport (GO:0006818) | 3.26170727 |
| 38 | protein prenylation (GO:0018342) | 3.24704193 |
| 39 | prenylation (GO:0097354) | 3.24704193 |
| 40 | protein neddylation (GO:0045116) | 3.23093455 |
| 41 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.22528590 |
| 42 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.21988549 |
| 43 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.19349476 |
| 44 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.19285284 |
| 45 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.19285284 |
| 46 | signal peptide processing (GO:0006465) | 3.17899465 |
| 47 | cell wall macromolecule metabolic process (GO:0044036) | 3.16619840 |
| 48 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.15269880 |
| 49 | protein refolding (GO:0042026) | 3.08160676 |
| 50 | regulation of interleukin-8 secretion (GO:2000482) | 3.07490715 |
| 51 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.06889559 |
| 52 | negative regulation of growth of symbiont in host (GO:0044130) | 3.05701003 |
| 53 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.05701003 |
| 54 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.05701003 |
| 55 | regulation of growth of symbiont in host (GO:0044126) | 3.05701003 |
| 56 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.04547912 |
| 57 | ATP biosynthetic process (GO:0006754) | 3.02319202 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.98302671 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96851992 |
| 60 | protein localization to cilium (GO:0061512) | 2.95886090 |
| 61 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94185120 |
| 62 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94185120 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 2.93555178 |
| 64 | secretory granule organization (GO:0033363) | 2.92487022 |
| 65 | protein complex biogenesis (GO:0070271) | 2.92341811 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91592465 |
| 67 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.89901534 |
| 68 | membrane budding (GO:0006900) | 2.88086197 |
| 69 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.86371594 |
| 70 | regulation of glucokinase activity (GO:0033131) | 2.84772470 |
| 71 | regulation of hexokinase activity (GO:1903299) | 2.84772470 |
| 72 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.83961004 |
| 73 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.82441855 |
| 74 | DNA deamination (GO:0045006) | 2.80308052 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.77866749 |
| 76 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76490921 |
| 77 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76490921 |
| 78 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76490921 |
| 79 | amino acid salvage (GO:0043102) | 2.74986435 |
| 80 | L-methionine salvage (GO:0071267) | 2.74986435 |
| 81 | L-methionine biosynthetic process (GO:0071265) | 2.74986435 |
| 82 | positive regulation of cell cycle G1/S phase transition (GO:1902808) | 2.74694158 |
| 83 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74162017 |
| 84 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74162017 |
| 85 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.73870033 |
| 86 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.73533071 |
| 87 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.73469270 |
| 88 | regulation of glomerular filtration (GO:0003093) | 2.72791595 |
| 89 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.72040230 |
| 90 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.71545885 |
| 91 | histone H2A acetylation (GO:0043968) | 2.71321804 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.69933901 |
| 93 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69541987 |
| 94 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69541987 |
| 95 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69541987 |
| 96 | histone mRNA metabolic process (GO:0008334) | 2.68808074 |
| 97 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.68259628 |
| 98 | negative regulation of cation channel activity (GO:2001258) | 2.67765799 |
| 99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.66226557 |
| 100 | S-adenosylmethionine metabolic process (GO:0046500) | 2.65174373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.02594856 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.37839696 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.54352493 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.37555801 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.35836082 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.16825538 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.63421786 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.54520206 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43390570 |
| 10 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.37878729 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.26211197 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22177253 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.09869816 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09130461 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.06310284 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 2.00900333 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99420309 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95805878 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91904415 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91331928 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85669176 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85443563 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84066010 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83663217 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78012811 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77763485 |
| 27 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.71714300 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69542044 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.67750679 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65140838 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.61434846 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56857890 |
| 33 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.56636836 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55337912 |
| 35 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.53191758 |
| 36 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.53191758 |
| 37 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.51371774 |
| 38 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.51371774 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50562292 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48229341 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47566018 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43093175 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38468725 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38086512 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36719418 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35092028 |
| 47 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.27963605 |
| 48 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26245120 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26038851 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24167047 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23615716 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22553633 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21881663 |
| 54 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.20772348 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20162597 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18841643 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18550191 |
| 58 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18548877 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17933031 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17857248 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17857248 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16578093 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16216935 |
| 64 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15883802 |
| 65 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14617474 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13894688 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13596414 |
| 68 | GATA3_26560356_Chip-Seq_TH1_Human | 1.13568438 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13023689 |
| 70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.12224665 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09466275 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08351311 |
| 73 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06021328 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05784096 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04918939 |
| 76 | MYB_26560356_Chip-Seq_TH2_Human | 1.04584359 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04382220 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04260055 |
| 79 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03529624 |
| 80 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01596948 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01593971 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01351028 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00917063 |
| 84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99911641 |
| 85 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.99356482 |
| 86 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.98383459 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97671546 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.97262384 |
| 89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.95191197 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92989874 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92833451 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92533145 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90224340 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89158868 |
| 95 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88846227 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.88032979 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87530111 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87515205 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87305308 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87287032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.39376895 |
| 2 | MP0002166_altered_tumor_susceptibility | 3.19919371 |
| 3 | MP0003880_abnormal_central_pattern | 3.12448690 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.11141077 |
| 5 | MP0009785_altered_susceptibility_to | 3.01508847 |
| 6 | MP0005671_abnormal_response_to | 2.92105170 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.81734246 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.79846593 |
| 9 | MP0006072_abnormal_retinal_apoptosis | 2.54488531 |
| 10 | MP0002006_tumorigenesis | 2.33179886 |
| 11 | MP0009764_decreased_sensitivity_to | 2.32793675 |
| 12 | MP0003724_increased_susceptibility_to | 2.22832278 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.21705769 |
| 14 | MP0001905_abnormal_dopamine_level | 2.06074592 |
| 15 | MP0000516_abnormal_urinary_system | 2.06037690 |
| 16 | MP0005367_renal/urinary_system_phenotyp | 2.06037690 |
| 17 | MP0001853_heart_inflammation | 2.05121526 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 1.98126407 |
| 19 | MP0001800_abnormal_humoral_immune | 1.92966440 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.82294579 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.71393432 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 1.67436603 |
| 23 | MP0003283_abnormal_digestive_organ | 1.64809052 |
| 24 | MP0000858_altered_metastatic_potential | 1.64396359 |
| 25 | MP0005253_abnormal_eye_physiology | 1.63388147 |
| 26 | MP0004742_abnormal_vestibular_system | 1.61987035 |
| 27 | MP0001529_abnormal_vocalization | 1.57243841 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.52973195 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52232784 |
| 30 | MP0003186_abnormal_redox_activity | 1.51679887 |
| 31 | MP0004142_abnormal_muscle_tone | 1.50805022 |
| 32 | MP0002102_abnormal_ear_morphology | 1.48437180 |
| 33 | MP0002736_abnormal_nociception_after | 1.46505384 |
| 34 | MP0003866_abnormal_defecation | 1.43633639 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.43088322 |
| 36 | MP0002723_abnormal_immune_serum | 1.41722500 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.38128144 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.37579250 |
| 39 | MP0009046_muscle_twitch | 1.35835232 |
| 40 | MP0000685_abnormal_immune_system | 1.35189553 |
| 41 | MP0002419_abnormal_innate_immunity | 1.32399141 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.29820994 |
| 43 | MP0002272_abnormal_nervous_system | 1.28508306 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.28329581 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.26978786 |
| 46 | MP0004147_increased_porphyrin_level | 1.24873971 |
| 47 | MP0001188_hyperpigmentation | 1.23619332 |
| 48 | MP0001542_abnormal_bone_strength | 1.22345534 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.18515330 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.18270681 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.17958220 |
| 52 | MP0008469_abnormal_protein_level | 1.16307407 |
| 53 | MP0005408_hypopigmentation | 1.14320628 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.14040964 |
| 55 | MP0001873_stomach_inflammation | 1.13237225 |
| 56 | MP0001819_abnormal_immune_cell | 1.12923993 |
| 57 | MP0003252_abnormal_bile_duct | 1.11094417 |
| 58 | MP0005025_abnormal_response_to | 1.10106839 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.08689495 |
| 60 | MP0005535_abnormal_body_temperature | 1.06381822 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.05212427 |
| 62 | MP0003787_abnormal_imprinting | 1.03554869 |
| 63 | MP0001756_abnormal_urination | 1.03516219 |
| 64 | MP0003195_calcinosis | 1.01791760 |
| 65 | MP0001845_abnormal_inflammatory_respons | 0.99367410 |
| 66 | MP0003075_altered_response_to | 0.95484270 |
| 67 | MP0003718_maternal_effect | 0.95097721 |
| 68 | MP0005451_abnormal_body_composition | 0.93168217 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.91532953 |
| 70 | MP0008872_abnormal_physiological_respon | 0.90905842 |
| 71 | MP0009745_abnormal_behavioral_response | 0.89606931 |
| 72 | MP0006082_CNS_inflammation | 0.89472209 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.88228397 |
| 74 | MP0008995_early_reproductive_senescence | 0.87390817 |
| 75 | MP0001790_abnormal_immune_system | 0.87116494 |
| 76 | MP0005387_immune_system_phenotype | 0.87116494 |
| 77 | MP0002751_abnormal_autonomic_nervous | 0.86414472 |
| 78 | MP0002009_preneoplasia | 0.85713498 |
| 79 | MP0005166_decreased_susceptibility_to | 0.84503233 |
| 80 | MP0002163_abnormal_gland_morphology | 0.84360603 |
| 81 | MP0009763_increased_sensitivity_to | 0.83152019 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.81202099 |
| 83 | MP0001486_abnormal_startle_reflex | 0.78838845 |
| 84 | MP0001970_abnormal_pain_threshold | 0.78475646 |
| 85 | MP0003878_abnormal_ear_physiology | 0.77416945 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.77416945 |
| 87 | MP0005332_abnormal_amino_acid | 0.76220708 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.75895203 |
| 89 | MP0004883_abnormal_blood_vessel | 0.75168677 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 0.74654384 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.73143308 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.73143308 |
| 93 | MP0003786_premature_aging | 0.72670821 |
| 94 | MP0005266_abnormal_metabolism | 0.72511761 |
| 95 | MP0000383_abnormal_hair_follicle | 0.72003433 |
| 96 | MP0000716_abnormal_immune_system | 0.67847249 |
| 97 | MP0005360_urolithiasis | 0.67784251 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.67104206 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.66074733 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.65235894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 4.98215212 |
| 2 | Hyperalaninemia (HP:0003348) | 4.98215212 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.98215212 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 4.53644267 |
| 5 | Aplastic anemia (HP:0001915) | 4.21992151 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 4.03355680 |
| 7 | Generalized aminoaciduria (HP:0002909) | 3.86348761 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85679149 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85679149 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.85488786 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.85488786 |
| 12 | Renal cortical cysts (HP:0000803) | 3.80323133 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.60394850 |
| 14 | Microretrognathia (HP:0000308) | 3.54858815 |
| 15 | Hepatic necrosis (HP:0002605) | 3.48528273 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33125269 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.31414793 |
| 18 | Hepatocellular necrosis (HP:0001404) | 3.29021116 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28992504 |
| 20 | Congenital, generalized hypertrichosis (HP:0004540) | 3.19124521 |
| 21 | Hypoproteinemia (HP:0003075) | 3.17195170 |
| 22 | Acute encephalopathy (HP:0006846) | 3.04045736 |
| 23 | Increased CSF lactate (HP:0002490) | 3.02307986 |
| 24 | Facial diplegia (HP:0001349) | 2.99385805 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.77453279 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75994878 |
| 27 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.71013451 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 2.71013451 |
| 29 | Cerebral edema (HP:0002181) | 2.68300450 |
| 30 | Methylmalonic acidemia (HP:0002912) | 2.64520378 |
| 31 | Lactic acidosis (HP:0003128) | 2.58676298 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49183756 |
| 33 | Optic disc pallor (HP:0000543) | 2.43717174 |
| 34 | Amyotrophic lateral sclerosis (HP:0007354) | 2.43666687 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.41667002 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.37930552 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.37930552 |
| 38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.36127431 |
| 39 | Petechiae (HP:0000967) | 2.35822263 |
| 40 | Metaphyseal dysplasia (HP:0100255) | 2.35275690 |
| 41 | Decreased central vision (HP:0007663) | 2.34408769 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.34323050 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.32973305 |
| 44 | IgG deficiency (HP:0004315) | 2.32296537 |
| 45 | Increased serum lactate (HP:0002151) | 2.31120090 |
| 46 | Ureteral stenosis (HP:0000071) | 2.30749463 |
| 47 | Leukodystrophy (HP:0002415) | 2.30236172 |
| 48 | Hypothermia (HP:0002045) | 2.30160869 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.29593373 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.26110448 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.25418481 |
| 52 | Acute hepatic failure (HP:0006554) | 2.23768316 |
| 53 | Abnormality of the basal ganglia (HP:0002134) | 2.22405909 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.22280383 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.21916047 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.20996356 |
| 57 | Gangrene (HP:0100758) | 2.16537894 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15775359 |
| 59 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15631038 |
| 60 | Recurrent skin infections (HP:0001581) | 2.09102993 |
| 61 | Chronic sinusitis (HP:0011109) | 2.08998006 |
| 62 | Ureteral obstruction (HP:0006000) | 2.08304406 |
| 63 | Dyskinesia (HP:0100660) | 2.06467850 |
| 64 | Hemoptysis (HP:0002105) | 2.03657029 |
| 65 | Spastic paraparesis (HP:0002313) | 2.03109987 |
| 66 | Alveolar cell carcinoma (HP:0006519) | 2.02956632 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99570764 |
| 68 | Obstructive lung disease (HP:0006536) | 1.97670242 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97670242 |
| 70 | Short middle phalanx of the 5th finger (HP:0004220) | 1.94627488 |
| 71 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93576867 |
| 72 | Bronchitis (HP:0012387) | 1.92259645 |
| 73 | Recurrent fungal infections (HP:0002841) | 1.90892365 |
| 74 | Exertional dyspnea (HP:0002875) | 1.90690892 |
| 75 | Retinal dysplasia (HP:0007973) | 1.88792779 |
| 76 | Central scotoma (HP:0000603) | 1.88650375 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88138976 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 1.88138976 |
| 79 | Respiratory failure (HP:0002878) | 1.85829016 |
| 80 | Basal ganglia calcification (HP:0002135) | 1.85669109 |
| 81 | Flat capital femoral epiphysis (HP:0003370) | 1.84283259 |
| 82 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83235878 |
| 83 | Nemaline bodies (HP:0003798) | 1.82063546 |
| 84 | Abnormality of serum amino acid levels (HP:0003112) | 1.79829214 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79328674 |
| 86 | Methylmalonic aciduria (HP:0012120) | 1.78594940 |
| 87 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.78502529 |
| 88 | Cleft eyelid (HP:0000625) | 1.77278670 |
| 89 | Abnormality of dental color (HP:0011073) | 1.77040858 |
| 90 | Abnormality of the pleura (HP:0002103) | 1.74455175 |
| 91 | Muscle fiber atrophy (HP:0100295) | 1.74225033 |
| 92 | Abnormality of secondary sexual hair (HP:0009888) | 1.73920416 |
| 93 | Abnormality of the axillary hair (HP:0100134) | 1.73920416 |
| 94 | Chronic diarrhea (HP:0002028) | 1.73515034 |
| 95 | Renal Fanconi syndrome (HP:0001994) | 1.73357913 |
| 96 | Abnormality of macular pigmentation (HP:0008002) | 1.72956248 |
| 97 | Porencephaly (HP:0002132) | 1.71730051 |
| 98 | Stenosis of the external auditory canal (HP:0000402) | 1.71490623 |
| 99 | Neonatal respiratory distress (HP:0002643) | 1.71425816 |
| 100 | Short tibia (HP:0005736) | 1.70174866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 6.12820320 |
| 2 | CDK19 | 5.02660423 |
| 3 | MAP4K2 | 4.07280000 |
| 4 | MAP3K12 | 3.15037964 |
| 5 | ERBB3 | 2.74545291 |
| 6 | EPHA3 | 2.49164485 |
| 7 | NUAK1 | 2.35409637 |
| 8 | TXK | 2.24334950 |
| 9 | TLK1 | 2.11756701 |
| 10 | BCKDK | 2.06151743 |
| 11 | RPS6KA4 | 2.05699305 |
| 12 | FLT3 | 1.85087023 |
| 13 | TRPM7 | 1.84113207 |
| 14 | CSNK1G2 | 1.78766038 |
| 15 | MYLK | 1.78589895 |
| 16 | CSF1R | 1.77345214 |
| 17 | TAOK3 | 1.73979203 |
| 18 | CDK8 | 1.70512605 |
| 19 | OXSR1 | 1.65978740 |
| 20 | PINK1 | 1.62959542 |
| 21 | CSNK1G3 | 1.53926251 |
| 22 | KIT | 1.53614773 |
| 23 | WNK3 | 1.47253018 |
| 24 | DYRK2 | 1.46832884 |
| 25 | MAP3K4 | 1.39528592 |
| 26 | RIPK4 | 1.37020775 |
| 27 | CSNK1A1L | 1.29908435 |
| 28 | MST4 | 1.20353555 |
| 29 | GRK1 | 1.19753427 |
| 30 | CSNK1G1 | 1.12461021 |
| 31 | KDR | 1.11443427 |
| 32 | IKBKB | 1.08952999 |
| 33 | RPS6KA5 | 1.01549744 |
| 34 | MAP2K7 | 0.94478596 |
| 35 | SIK3 | 0.92052388 |
| 36 | PRKCE | 0.91069116 |
| 37 | ILK | 0.89549770 |
| 38 | MKNK1 | 0.86974413 |
| 39 | SCYL2 | 0.84632904 |
| 40 | ADRBK2 | 0.83667469 |
| 41 | INSRR | 0.80919863 |
| 42 | VRK1 | 0.80490904 |
| 43 | TEC | 0.76915883 |
| 44 | STK16 | 0.76064283 |
| 45 | FRK | 0.74447113 |
| 46 | UHMK1 | 0.72262650 |
| 47 | CCNB1 | 0.72062077 |
| 48 | DYRK3 | 0.66089810 |
| 49 | MUSK | 0.65817158 |
| 50 | OBSCN | 0.65650378 |
| 51 | SRPK1 | 0.62535866 |
| 52 | ABL2 | 0.60205618 |
| 53 | DAPK1 | 0.59938871 |
| 54 | CAMK2D | 0.59653234 |
| 55 | MAPK13 | 0.59372041 |
| 56 | MARK3 | 0.58429468 |
| 57 | BTK | 0.56396924 |
| 58 | EGFR | 0.56019244 |
| 59 | BLK | 0.54918651 |
| 60 | ITK | 0.54668668 |
| 61 | WNK1 | 0.51530396 |
| 62 | PRKG1 | 0.51112721 |
| 63 | LYN | 0.50799527 |
| 64 | MINK1 | 0.50441346 |
| 65 | ABL1 | 0.49129036 |
| 66 | FGFR1 | 0.48696968 |
| 67 | SYK | 0.47307393 |
| 68 | DAPK3 | 0.46327390 |
| 69 | TNIK | 0.45008538 |
| 70 | NME1 | 0.44868408 |
| 71 | WNK4 | 0.44791121 |
| 72 | PLK2 | 0.44618067 |
| 73 | CSNK2A1 | 0.43792882 |
| 74 | EPHA4 | 0.43594234 |
| 75 | LCK | 0.43505829 |
| 76 | HCK | 0.42507651 |
| 77 | PAK4 | 0.42321859 |
| 78 | CAMK2A | 0.40077582 |
| 79 | MAP3K14 | 0.39899602 |
| 80 | SIK2 | 0.38591829 |
| 81 | TIE1 | 0.36802694 |
| 82 | CSNK1A1 | 0.36748306 |
| 83 | PRKACA | 0.36426933 |
| 84 | IGF1R | 0.36090765 |
| 85 | PTK2B | 0.35969811 |
| 86 | IKBKE | 0.35826000 |
| 87 | CSNK2A2 | 0.34270993 |
| 88 | PRKCB | 0.33160888 |
| 89 | PAK1 | 0.32968241 |
| 90 | CHUK | 0.32447024 |
| 91 | CDK14 | 0.30773471 |
| 92 | JAK3 | 0.30040672 |
| 93 | PHKG1 | 0.29749010 |
| 94 | PHKG2 | 0.29749010 |
| 95 | CSNK1D | 0.28998292 |
| 96 | PRKACG | 0.28882302 |
| 97 | PRKCA | 0.28824425 |
| 98 | CAMK2B | 0.28156617 |
| 99 | BCR | 0.27135926 |
| 100 | HIPK2 | 0.26621396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.92211711 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.93200798 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.81216429 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.77034690 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.42138157 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.26184100 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 3.23306163 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.18865202 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.00903306 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.67141833 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.57287359 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34993980 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.13135021 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.06953968 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06652143 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05392556 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68715082 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64104501 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62690665 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56648554 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44098104 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.38984049 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30515992 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.28441043 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25340878 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.22266826 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11722813 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01235667 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98134911 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 0.95917484 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95681258 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88834777 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87838097 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 0.86986337 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 0.86310862 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82065806 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 0.79918406 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76201181 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71502115 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68781659 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68590749 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 0.68177691 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66156670 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58828595 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56333169 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53449182 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53112740 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 0.52864415 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51931617 |
| 50 | RNA transport_Homo sapiens_hsa03013 | 0.50704574 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.50625156 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49507976 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.49078366 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47204092 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47202479 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46905560 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45571823 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45043116 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44384390 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43781852 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43230783 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.43141344 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.42281796 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41772896 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.41426895 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.41322300 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40409225 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40181580 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.40130073 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.40124770 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.39432660 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38922294 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38611674 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.35304387 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34926986 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34229378 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33195315 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31774752 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30323543 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29382808 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29160745 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29051313 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27887747 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27603215 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.26937177 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25832924 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.25505529 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25377199 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.24751491 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24567428 |
| 91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23426653 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22593865 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21783697 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21690318 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.20990787 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.20518789 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.20094495 |
| 98 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19766432 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19280542 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.17775282 |

